Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2026-03-05 @ 12:53 PM
Study NCT ID:
NCT01488318
Status:
TERMINATED
Last Update Posted:
2018-01-05
First Post:
2011-11-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Sponsor:
Julie E. Bauman, MD, MPH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
ACTUAL
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-30
First Submit QC Date:
None
Study First Post Date:
2011-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-08
Results First Submit QC Date:
None
Results First Post Date:
2018-01-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-07
Last Update Post Date:
2018-01-05
Last Update Post Date Type:
ACTUAL